Transparent Thinking Blog
The EU Clinical Trial Regulation obliges clinical trial sponsors to submit the result of their drug trials to the Clinical Trials Information System (CTIS), a new European trial registry due to be launched in late 2021.
Read the latest transparency news in the pharma, biotech, and medical device industries from January 30 – February 12, 2021.
Review news of transparency, disclosure, data sharing, and communication in clinical trials for the weeks of January 9-29, 2021.
Read the latest clinical trial disclosure and data transparency news from December 19, 2020 – January 8, 2021.
Start drafting plain language summaries (lay summaries) now or get left behind. Dowload this free resources to learn more.
News from the pharmaceutical industry on clinical data sharing, trial transparency, and disclosures for the weeks of Dec. 5-18, 2020.
This week in transparency news features clinical trial disclosure and data transparency news from November 21 – December 4, 2020. Read now!
Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories from November 7-20, 2020 are included.
Clinical trial transparency in the pharmaceutical industry is continually evolving, and to stay on top of the news, TrialAssure brings a bi-weekly round-up of some of the key stories. Select recent and relevant stories are as follows:
The FDA provided insight into their overall vision for clinical trial transparency last week, announcing a new program to publicly release clinical study reports (CSRs) that accompany drug approval submissions. They plan to pilot nine recently-approved drugs (yet to be determined) from volunteer sponsors, with CSRs to be posted to the FDA’s drug approval database, Drugs@FDA.